PMC:7600245 / 445-770 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":158,"end":167},"obj":"Disease"},{"id":"T5","span":{"begin":210,"end":218},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ivir and dexamethasone. Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. Previously, we reviewed the potential therapeutics in clini"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":9,"end":22},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"}],"text":"ivir and dexamethasone. Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. Previously, we reviewed the potential therapeutics in clini"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":24,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ivir and dexamethasone. Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. Previously, we reviewed the potential therapeutics in clini"}

{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":9,"end":22},"obj":"Chemical"},{"id":"22","span":{"begin":158,"end":167},"obj":"Disease"},{"id":"23","span":{"begin":210,"end":218},"obj":"Disease"},{"id":"24","span":{"begin":250,"end":259},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D003907"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:D007239"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:C000657245"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ivir and dexamethasone. Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. Previously, we reviewed the potential therapeutics in clini"}